Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002094 |
---|---|
Receipt number | R000002513 |
Scientific Title | Multicenter PhaseII study of Combination FOLFIRI with Erbitux in advanced/metastatic colorectal cancer: EGFR positive and KRAS wild type |
Date of disclosure of the study information | 2009/06/22 |
Last modified on | 2018/09/20 08:20:07 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/06/19 12:10:55 | ||
2 | Update | 2009/07/06 15:27:42 | Interventions/Control_1 Interventions/Control_1 |
|
3 | Update | 2010/01/13 16:01:35 | Recruitment status |
|
4 | Update | 2010/09/28 22:16:38 | Public title |
|
5 | Update | 2010/12/23 16:51:56 | Address Address |
|
6 | Update | 2011/08/05 19:43:10 | Institute Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
7 | Update | 2012/06/08 10:55:24 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL |
|
8 | Update | 2012/08/29 12:58:30 | Email |
|
9 | Update | 2013/09/01 17:35:19 | Email Last name of contact person Last name of contact person Address |
|
10 | Update | 2014/07/25 11:52:53 | Recruitment status Publication of results Results |
|
11 | Update | 2015/07/02 21:38:40 | Key exclusion criteria |
|
12 | Update | 2015/07/02 21:41:36 | Results |
|
13 | Update | 2015/11/18 09:40:19 | Recruitment status Results Other related information |
|
14 | Update | 2016/04/04 16:05:55 | Name of primary person or sponsor Organization |
|
15 | Update | 2018/09/20 08:20:07 | Recruitment status |